Celgene Acquisitions
Celgene has acquired 11 companies and its latest acquisition was Impact Biomedicines on Jan 2018
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Impact Biomedicines
Jan 2018
Source »$1.1B
Impact Biomedicines is a biotechnological company that develops treatments for patients with myeloproliferative neoplasms and other types of cancers.
Juno Therapeutics, Inc.
Jan 2018
Source »$9B
Juno is a biopharmaceutical company that researches and develops cellular immunotherapies for the treatment of cancer.
Anokion SA
Jan 2017
Source »$45M
Anokion is a Switzerland-based biotechnology company that researches and develops antigen-specific immune tolerance therapies for the treatment of autoimmune diseases.
Frequently Asked Questions about Celgene
What companies did Celgene acquire?
Companies acquired by Celgene include Impact Biomedicines, Juno Therapeutics and AnokionHow many acquisitions does Celgene have?
Celgene has acquired 11 companies including Impact Biomedicines, Juno Therapeutics and Anokion.
How many acquisitions did Celgene make in 2018?
In 2018 Celgene acquired 2 companies including Impact Biomedicines and Juno Therapeutics.